Newsroom

Sorted by: Latest

-

Azelis: Transparency Notifications From UBS Group AG

ANTWERP, Belgium--(BUSINESS WIRE)--REGULATED INFORMATION In accordance with Article 14 of the Belgian Transparency law of 2 May 2007, Azelis Group NV (Brussels:AZE) announces that on 15 September 2026 and 17 September 2026, it has received two transparency notifications from UBS Group AG. 1. Summary of the notifications UBS Group AG reported in its notification dated 15 September 2026, that on 11 September 2026, following an acquisition of equivalent financial instruments, UBS Group AG (taking...
-

Azelis: Transparantiekennisgevingen UBS Group AG

ANTWERPEN, België--(BUSINESS WIRE)--GEREGULEERDE INFORMATIE In overeenstemming met artikel 14 van de Belgische Transparantiewet van 2 mei 2007 maakt Azelis Group NV (Brussels:AZE) bekend dat het twee transparantiekennisgevingen heeft ontvangen van UBS Group AG op 15 september 2026 en 17 september 2026. 1. Samenvatting van de kennisgevingen UBS Group AG heeft in een kennisgeving gedateerd op 15 september 2026 gemeld dat op 11 september 2026, na een verwerving van gelijkgestelde financiële instru...
-

ALIKO Scientific Announces Settlement of a Dispute Involving Its US Subsidiary, Which Will Receive USD 2 Million

PARIS--(BUSINESS WIRE)--Regulatory News: ALIKO Scientific (Ikonisys SA – Euronext Growth Paris: ALIKO), an international life sciences Group dedicated to integrated oncology diagnostics, announces that its wholly-owned US subsidiary has reached a settlement resolving an existing dispute, pursuant to which it will receive a payment of USD 2 million. The related proceedings have been dismissed. About ALIKO SCIENTIFIC Headquartered in Paris, ALIKO SCIENTIFIC is the parent company of an internation...
-

ALIKO Scientific annonce un accord transactionnel mettant fin à un litige concernant sa filiale américaine, qui percevra 2 millions de dollars américains

PARIS--(BUSINESS WIRE)--Regulatory News: ALIKO Scientific (Ikonisys SA – Euronext Growth Paris : ALIKO), groupe international des sciences de la vie dédié au diagnostic oncologique intégré, annonce que sa filiale américaine détenue à 100 % a conclu un accord transactionnel mettant fin à un litige en cours, aux termes duquel elle percevra la somme de 2 millions de dollars américains. Les procédures judiciaires relatives à ce litige ont été closes. À propos d’ALIKO SCIENTIFIC (Ikonisys SA) Basée...
-

Strongest Half-Year in Curatis’s History — Revenue up 51% and Significant Progress on Corticorelin (C-PTBE-01)

LIESTAL, Switzerland--(BUSINESS WIRE)--Curatis Holding AG (SIX:CURN, “Curatis”) reports net sales from goods and services of CHF 7.9m for the first half of 2026, up 51% (H1 2025: CHF 5.2m), with the loss for the period narrowing to CHF -0.4m (H1 2025: CHF -1.2m) and cash and cash equivalents rising to CHF 3.6m (31 December 2025: CHF 1.9m). Curatis also advanced its corticorelin (C-PTBE-01) program on multiple levels, including an exclusive Japan licence with Neupharma and continued manufacturin...
-

TeraSignal and Keysight to Demonstrate CMIS Link Training at OIF Booth #2126 During ECOC 2026

IRVINE, Calif.--(BUSINESS WIRE)--TeraSignal will demonstrate CMIS Link Training (CMIS-LT) with Keysight Technologies as part of the OIF interoperability demonstrations at ECOC 2026....
-

Marvell to Showcase Industry-First 2nm Optical Technology Demos for AI Data Center Infrastructure at ECOC 2026

SANTA CLARA, Calif.--(BUSINESS WIRE)--Marvell Technology, Inc. (NASDAQ: MRVL), a leader in data infrastructure semiconductor solutions, today announced industry-first 2nm optical interconnect demonstrations that advance the next generation of AI data center connectivity. The technologies will be showcased at the European Conference on Optical Communication (ECOC) 2026, September 20–24, 2026, in Málaga, Spain, underscoring how Marvell continually delivers new waves of advanced connectivity solut...
-

Galderma Begins Trading in the Swiss Market Index, Joining Switzerland's Leading Blue Chip Companies

ZUG, Switzerland--(BUSINESS WIRE)--Galderma (SIX: GALD), the pure-play dermatology category leader, today begins trading as a constituent of the Swiss Market Index (SMI), Switzerland's leading blue chip equity benchmark comprising 20 of the country's largest and most liquid listed companies. Less than three years after its IPO on the SIX Swiss Exchange in March 2024, Galderma has established itself as one of Switzerland's leading listed companies. Its inclusion in the SMI reflects the company's...
-

Northisle Announces Filing of NI 43-101 Technical Report for the North Island Project

VANCOUVER, British Columbia--(BUSINESS WIRE)--Northisle Copper and Gold Inc. (TSX-V: NCX, OTCQX: NTCPF) (“Northisle” or the “Company”) is pleased to announce that the Company has filed on SEDAR+ a technical report (the “Report”) prepared in accordance with National Instrument 43‐101 – Standards of Disclosure for Mineral Projects (“NI 43‐101”) titled “NI 43-101 Resource Estimate for the North Island Project 2026 Update” on the Company’s 100% owned North Island copper-gold project located in the...
-

2026 World Manufacturing Convention Opens in Hefei, Spotlighting New Opportunities for Global Intelligent Manufacturing Cooperation

HEFEI, China--(BUSINESS WIRE)--The 2026 World Manufacturing Convention is being held in Hefei, Anhui Province, from September 20 to 23. Under the theme “Intelligent Manufacturing for a Better Future,” the convention has attracted more than 1,000 government and business representatives and over 500 international delegates. More than 40 multinational companies from the United States, France, Russia and other countries are exhibiting in groups to explore new opportunities for intelligent manufactu...